EVOLENT HEALTH INC - A (EVH) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:EVH - US30050B1017 - Common Stock
3.89 USD
-0.11 (-2.75%)
3.9585 USD
+0.07 (+1.76%)
Taking everything into account, EVH scores 2 out of 10 in our fundamental rating. EVH was compared to 35 industry peers in the Health Care Technology industry. EVH may be in some trouble as it scores bad on both profitability and health. EVH is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year EVH has reported negative net income.
EVH had a negative operating cash flow in the past year.
In the past 5 years EVH always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: EVH reported negative operating cash flow in multiple years.
1.2 Ratios
EVH has a better Return On Assets (-7.37%) than 62.86% of its industry peers.
EVH's Return On Equity of -21.48% is in line compared to the rest of the industry. EVH outperforms 60.00% of its industry peers.
EVH's Return On Invested Capital of 0.68% is in line compared to the rest of the industry. EVH outperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.37% | ||
| ROE | -21.48% | ||
| ROIC | 0.68% |
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 0.86%, EVH is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
EVH's Gross Margin of 18.42% is on the low side compared to the rest of the industry. EVH is outperformed by 85.71% of its industry peers.
EVH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.86% | ||
| PM (TTM) | N/A | ||
| GM | 18.42% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EVH is destroying value.
Compared to 1 year ago, EVH has more shares outstanding
EVH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EVH is higher compared to a year ago.
2.2 Solvency
EVH has an Altman-Z score of 0.59. This is a bad value and indicates that EVH is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.59, EVH is in line with its industry, outperforming 54.29% of the companies in the same industry.
A Debt/Equity ratio of 1.26 is on the high side and indicates that EVH has dependencies on debt financing.
The Debt to Equity ratio of EVH (1.26) is worse than 88.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.59 |
ROIC/WACC0.09
WACC7.94%
2.3 Liquidity
EVH has a Current Ratio of 1.33. This is a normal value and indicates that EVH is financially healthy and should not expect problems in meeting its short term obligations.
EVH has a worse Current ratio (1.33) than 65.71% of its industry peers.
A Quick Ratio of 1.33 indicates that EVH should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.33, EVH is doing worse than 65.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.33 |
3. Growth
3.1 Past
The earnings per share for EVH have decreased strongly by -101.10% in the last year.
EVH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 220.75% yearly.
The Revenue for EVH has decreased by -16.65% in the past year. This is quite bad
Measured over the past years, EVH shows a very strong growth in Revenue. The Revenue has been growing by 30.04% on average per year.
EPS 1Y (TTM)-101.1%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)-16.65%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-22.83%
3.2 Future
EVH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 8.00% yearly.
The Revenue is expected to grow by 6.63% on average over the next years.
EPS Next Y-88.84%
EPS Next 2Y-26.91%
EPS Next 3Y-7.47%
EPS Next 5Y8%
Revenue Next Year-26.69%
Revenue Next 2Y-3.16%
Revenue Next 3Y2.01%
Revenue Next 5Y6.63%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for EVH. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 11.03, the valuation of EVH can be described as very reasonable.
Based on the Price/Forward Earnings ratio, EVH is valued cheaply inside the industry as 88.57% of the companies are valued more expensively.
EVH is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.03 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EVH is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 11.76 |
4.3 Compensation for Growth
EVH's earnings are expected to decrease with -7.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-26.91%
EPS Next 3Y-7.47%
5. Dividend
5.1 Amount
EVH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
3.89
-0.11 (-2.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners123.68%
Inst Owner Change6.57%
Ins Owners1.62%
Ins Owner Change1.11%
Market Cap434.12M
Revenue(TTM)2.05B
Net Income(TTM)-180.88M
Analysts85.26
Price Target10.38 (166.84%)
Short Float %17.81%
Short Ratio4.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-139.54%
Min EPS beat(2)-226.45%
Max EPS beat(2)-52.63%
EPS beat(4)0
Avg EPS beat(4)-162.45%
Min EPS beat(4)-332.96%
Max EPS beat(4)-37.77%
EPS beat(8)3
Avg EPS beat(8)-78.52%
EPS beat(12)6
Avg EPS beat(12)-25.77%
EPS beat(16)10
Avg EPS beat(16)442.42%
Revenue beat(2)1
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-4.24%
Max Revenue beat(2)1.56%
Revenue beat(4)2
Avg Revenue beat(4)-0.09%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)4.03%
Revenue beat(8)5
Avg Revenue beat(8)0.67%
Revenue beat(12)7
Avg Revenue beat(12)0.38%
Revenue beat(16)10
Avg Revenue beat(16)1.03%
PT rev (1m)-8.95%
PT rev (3m)-35.03%
EPS NQ rev (1m)-16.73%
EPS NQ rev (3m)-53.28%
EPS NY rev (1m)-70.36%
EPS NY rev (3m)-70.11%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-2.56%
Revenue NY rev (1m)-0.42%
Revenue NY rev (3m)-0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.03 | ||
| P/S | 0.21 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.52 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.76 |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.35
Fwd EY9.06%
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS18.41
BVpS7.55
TBVpS-7.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.37% | ||
| ROE | -21.48% | ||
| ROCE | 0.87% | ||
| ROIC | 0.68% | ||
| ROICexc | 0.73% | ||
| ROICexgc | 6.52% | ||
| OM | 0.86% | ||
| PM (TTM) | N/A | ||
| GM | 18.42% | ||
| FCFM | N/A |
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
F-Score4
Asset Turnover0.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.26 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.01 | ||
| Cap/Depr | 32.44% | ||
| Cap/Sales | 1.58% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.33 | ||
| Altman-Z | 0.59 |
F-Score4
WACC7.94%
ROIC/WACC0.09
Cap/Depr(3y)38.35%
Cap/Depr(5y)41.66%
Cap/Sales(3y)1.98%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-101.1%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y-88.84%
EPS Next 2Y-26.91%
EPS Next 3Y-7.47%
EPS Next 5Y8%
Revenue 1Y (TTM)-16.65%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-22.83%
Revenue Next Year-26.69%
Revenue Next 2Y-3.16%
Revenue Next 3Y2.01%
Revenue Next 5Y6.63%
EBIT growth 1Y218.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year297.61%
EBIT Next 3Y71.11%
EBIT Next 5Y48.15%
FCF growth 1Y-223.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-140.71%
OCF growth 3Y-21.47%
OCF growth 5YN/A
EVOLENT HEALTH INC - A / EVH FAQ
What is the fundamental rating for EVH stock?
ChartMill assigns a fundamental rating of 2 / 10 to EVH.
Can you provide the valuation status for EVOLENT HEALTH INC - A?
ChartMill assigns a valuation rating of 3 / 10 to EVOLENT HEALTH INC - A (EVH). This can be considered as Overvalued.
Can you provide the profitability details for EVOLENT HEALTH INC - A?
EVOLENT HEALTH INC - A (EVH) has a profitability rating of 2 / 10.
Can you provide the financial health for EVH stock?
The financial health rating of EVOLENT HEALTH INC - A (EVH) is 1 / 10.